Singapore markets closed

iX Biopharma Ltd. (42C.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.22000.0000 (0.00%)
At close: 4:58PM SGT
Currency in SGD

Valuation measures

Market cap (intra-day) 5152.54M
Enterprise value 3150.75M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)154.87
Price/book (mrq)13.75
Enterprise value/revenue 3153.04
Enterprise value/EBITDA 6-14.91

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 310.00%
S&P500 52-week change 312.20%
52-week high 30.3500
52-week low 30.1300
50-day moving average 30.2661
200-day moving average 30.2351

Share statistics

Avg vol (3-month) 310.11M
Avg vol (10-day) 37.02M
Shares outstanding 5693.39M
Float 325.39M
% held by insiders 153.95%
% held by institutions 11.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2020
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,133.20%

Management effectiveness

Return on assets (ttm)-31.95%
Return on equity (ttm)-68.47%

Income statement

Revenue (ttm)985k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)167.80%
Gross profit (ttm)-587k
EBITDA -10.11M
Net income avi to common (ttm)-10.5M
Diluted EPS (ttm)-0.0160
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.66M
Total cash per share (mrq)0.01
Total debt (mrq)3.92M
Total debt/equity (mrq)38.53
Current ratio (mrq)2.47
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-8.32M
Levered free cash flow (ttm)-5.89M